DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 234 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,197 | +14.3% | 555 | 0.0% | 0.00% | – |
Q2 2023 | $7,171 | +114.4% | 555 | +62.8% | 0.00% | – |
Q1 2023 | $3,345 | +362.0% | 341 | +401.5% | 0.00% | – |
Q4 2022 | $724 | -63.8% | 68 | -53.1% | 0.00% | – |
Q3 2022 | $2,000 | +100.0% | 145 | +113.2% | 0.00% | – |
Q2 2022 | $1,000 | -99.8% | 68 | -99.9% | 0.00% | -100.0% |
Q4 2021 | $645,000 | +32150.0% | 45,870 | +18248.0% | 0.00% | – |
Q2 2021 | $2,000 | -33.3% | 250 | -28.6% | 0.00% | – |
Q1 2021 | $3,000 | -40.0% | 350 | -50.0% | 0.00% | – |
Q1 2019 | $5,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |